Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review

Adult-onset Still's disease (AOSD) is often refractory to standard therapy. Anakinra (ANK), an interleukin-1 receptor antagonist, has demonstrated efficacy in single cases and small series of AOSD. We assessed the efficacy of ANK in a series of AOSD patients. Multicenter retrospective open-labe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortiz-Sanjuán, Francisco, Blanco, Ricardo, Riancho-Zarrabeitia, Leyre, Castañeda, Santos, Olivé, Alejandro, Riveros, Anne, Velloso-Feijoo, María.L., Narváez, Javier, Jiménez-Moleón, Inmaculada, Maiz-Alonso, Olga, Ordóñez, Carmen, Bernal, José A., Hernández, María V., Sifuentes-Giraldo, Walter A., Gómez-Arango, Catalina, Galíndez-Agirregoikoa, Eva, Blanco-Madrigal, Juan, Ortiz-Santamaria, Vera, del Blanco-Barnusell, Jordi, De Dios, Juan R., Moreno, Mireia, Fiter, Jordi, Riscos, Marina de los, Carreira, Patricia, Rodriguez-Valls, María J., González-Vela, M. Carmen, Calvo-Río, Vanesa, Loricera, Javier, Palmou-Fontana, Natalia, Pina, Trinitario, Llorca, Javier, González-Gay, Miguel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616841/
https://www.ncbi.nlm.nih.gov/pubmed/26426623
http://dx.doi.org/10.1097/MD.0000000000001554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616841/
https://www.ncbi.nlm.nih.gov/pubmed/26426623
http://dx.doi.org/10.1097/MD.0000000000001554

Ejemplares similares